High-Dose Vitamin C Reduces Inflammation in Cancer Patients Study Shows

Posted October 17, 2012
High inflammatory levels appear to indicate increased cancer risk and poorer prognosis. Inflammation also decreases quality of life, impairs immune functions, plays a central role in cancer cachexia, and lowers toleration of some anti-cancer therapies.  The existing level of inflammation may predict survival time for many cancers. People with the lowest levels of inflammation were twice as likely to live through the next several years.  This study analyzed the effect of high-dose intravenous vitamin C (IVC) treatment on inflammation in cancer patients.  Read more.